CS
NIOX Group Plc
CSSPF · OTC
$0.82 +0.00% (+$0.00)
Market Cap £255.6M
P/E Ratio 36.52x
Div. Yield 2.54%
ROE 10.02%
Bulios Fair Price
$0.41
50.0% downside
Current Price
$0.82
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CSSPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
47 /100
Fair P/E 36.52x
EV/EBITDA 22.13x
P/S 5.25x
Growth
58 /100
Stable EPS growth 23.27%
Rev. growth 15.87%
FCF growth 33.20%
Profitability
94 /100
Strong Gross margin 60.78%
Net margin 14.37%
Op. margin 21.97%
Quality
55 /100
Average ROIC 9.75%
ROE 10.02%
ROA 9.19%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 3.81x
Int. coverage 53.50x
Stability
55 /100
Moderate Beta -0.09x
Rev. volatility 2.06%
EPS volatility 86.46%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CSSPF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Jonathan Charles Emms
Employees
97
Headquarters
Oxford
Upcoming events
29 SEP
Earnings
Upcoming earnings report
23 MAR
Earnings
Upcoming earnings report